AtriCure, Inc. (ATRC)

↓ Download CSV

CIK 0001323885 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, AtriCure, Inc. reported revenue of $534.53M, up 14.9% from the prior year. The company ran a net loss, with a net margin of -2.1% and a gross margin of 75.0%. It held $654.18M in total assets against $162.24M in total liabilities.

Key ratios (FY2025)

75.0%
Gross margin
-1.8%
Operating margin
-2.1%
Net margin
-2.3%
Return on equity
+14.9%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$534.53M$465.31M$399.25M$330.38M$274.33M$206.53M$230.81M$201.63M$174.72M$155.11M
Cost of Revenue$133.75M$117.78M$98.88M$84.44M$68.47M$57.22M$60.47M$54.51M$48.55M$44.01M
Gross Profit$400.78M$347.52M$300.37M$245.94M$205.86M$149.31M$170.34M$147.12M$126.16M$111.10M
Operating Income-$9.45M-$40.01M-$26.68M-$42.67M$55.20M-$44.23M-$33.12M-$17.13M-$24.98M-$31.14M
Net Income-$11.45M-$44.70M-$30.44M-$46.47M$50.20M-$48.16M-$35.19M-$21.14M-$26.89M-$33.34M
EPS (Diluted)$-0.24$-0.95$-0.66$-1.02$1.09$-1.14$-0.94
Total Assets$654.18M$609.33M$613.93M$585.45M$615.31M$714.54M$557.88M$356.76M$267.70M$276.42M
Total Liabilities$162.24M$148.36M$147.76M$128.69M$131.56M$302.14M$310.54M$107.38M$106.54M$107.98M
Shareholders' Equity$491.94M$460.97M$466.17M$456.75M$483.76M$412.39M$247.34M$249.38M$161.17M$168.44M
Cash & Equivalents$167.43M$122.72M$84.31M$58.10M$43.65M$41.94M$28.48M$32.23M$21.81M$24.21M
Operating Cash Flow$57.33M$12.20M$4.48M-$22.14M-$13.78M-$19.87M-$15.81M-$4.17M-$8.94M-$15.12M
Capital Expenditures$9.05M$11.46M$12.00M$16.88M$9.75M$5.26M$12.18M$6.21M$6.38M$7.69M
Shares Outstanding49.79M48.87M47.53M46.56M46.02M45.35M39.66M38.60M34.59M33.34M